Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?

Müller, F H H; Farahati, J; Müller, A G; Gillman, E; Hentschel, Michael (2016). Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection? Nuklearmedizin / Nuclear medicine, 55(1), pp. 15-20. Schattauer 10.3413/Nukmed-0753-15-07

[img] Text
Positron emission mammography in the diagnosis of breast cancer..pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (843kB) | Request a copy

AIM To evaluate the diagnostic value (sensitivity, specificity) of positron emission mammography (PEM) in a single site non-interventional study using the maximum PEM uptake value (PUVmax). PATIENTS, METHODS In a singlesite, non-interventional study, 108 patients (107 women, 1 man) with a total of 151 suspected lesions were scanned with a PEM Flex Solo II (Naviscan) at 90 min p.i. with 3.5 MBq 18F-FDG per kg of body weight. In this ROI(region of interest)-based analysis, maximum PEM uptake value (PUV) was determined in lesions, tumours (PUVmaxtumour), benign lesions (PUVmaxnormal breast) and also in healthy tissues on the contralateral side (PUVmaxcontralateral breast). These values were compared and contrasted. In addition, the ratios of PUVmaxtumour / PUVmaxcontralateral breast and PUVmaxnormal breast / PUVmaxcontralateral breast were compared. The image data were interpreted independently by two experienced nuclear medicine physicians and compared with histology in cases of suspected carcinoma. RESULTS Based on a criteria of PUV>1.9, 31 out of 151 lesions in the patient cohort were found to be malignant (21%). A mean PUVmaxtumour of 3.78 ± 2.47 was identified in malignant tumours, while a mean PUVmaxnormal breast of 1.17 ± 0.37 was reported in the glandular tissue of the healthy breast, with the difference being statistically significant (p < 0.001). Similarly, the mean ratio between tumour and healthy glandular tissue in breast cancer patients (3.15 ± 1.58) was found to be significantly higher than the ratio for benign lesions (1.17 ± 0.41, p < 0.001). CONCLUSION PEM is capable of differentiating breast tumours from benign lesions with 100% sensitivity along with a high specificity of 96%, when a threshold of PUVmax >1.9 is applied.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Hentschel, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0029-5566

Publisher:

Schattauer

Language:

English

Submitter:

Franziska Nicoletti

Date Deposited:

03 Mar 2016 10:09

Last Modified:

23 Oct 2019 05:35

Publisher DOI:

10.3413/Nukmed-0753-15-07

PubMed ID:

26627876

Uncontrolled Keywords:

Positron emission tomography; benign tumours; breast cancer; malign tumours

BORIS DOI:

10.7892/boris.76672

URI:

https://boris.unibe.ch/id/eprint/76672

Actions (login required)

Edit item Edit item
Provide Feedback